Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users

Inclusion Criteria: * English speaking * Women 15-45 years of age * Currently using the ENG implant for at least 30 days and use proven on exam (palpation of implant at screening visit) * Willing to continue using the implant for at least 30 days from study enrollment * \>7 days of continuous bleeding/spotting in the last 30 days, OR 2 or more episodes of bleeding/spotting in the last 30 days. * Access to a reliable cell phone and must be willing to receive and respond to a daily text or email message to assess bleeding and use of study drug * Negative gonorrhea/chlamydia screening performed at screening visit Exclusion Criteria: * Postpartum within six months * Post-abortion within six weeks * Currently pregnant * Currently breast-feeding (to be eligible, must be 4-6 weeks from cessation of breastfeeding) * Undiagnosed abnormal uterine bleeding pre-dating placement of contraceptive implant * Bleeding dyscrasia * Anticoagulation use * Active cervicitis * Allergy to curcumin or turmeric * History of venous thromboembolism * Current or past breast or uterine malignancy * Use of P450 pathway inducing drug * Implant is due to be switched out in 2 months or less from enrollment * Currently using oral contraceptives in addition to implant (to be eligible, needs to have a 4-6 week washout period) * Prior pregnancy occurred while Nexplanon/Implanon was in place